Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/1999
06/24/1999CA2314342A1 .beta.(1-3)-glucan diagnostic assays
06/23/1999EP0923953A2 Drug coating with topcoat
06/23/1999EP0923943A1 Micellar aqueous composition and method for solubilizing hydrophobic drug
06/23/1999EP0923942A1 5alpha-REDUCTASE INHIBITORY PREPARATION FOR ORAL ADMINISTRATION, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF
06/23/1999EP0923630A1 Cationic lipids and methods of use therefor
06/23/1999EP0923603A1 Oligopeptide transporters
06/23/1999EP0923566A1 High molecular weight polymer-based prodrugs
06/23/1999EP0923399A1 Novel methods for embolizing vascular sites with an embolizing composition comprising dimethylsulfoxide
06/23/1999EP0923383A1 Novel dispersible lipid blends and uses therefor
06/23/1999EP0923382A1 Compositions of plant carbohydrates as dietary supplements
06/23/1999EP0923380A1 Povidone iodine (pvp-i) alcohol gel antimicrobial pre-operative skin preparation
06/23/1999CN1220600A Tetrahydrolipstatin-containing compositions
06/23/1999CN1220598A Suspension of spraingly water-soluble acidic drug
06/23/1999CN1220288A The use of water-soluble or water-dispersible polyurethanes as coatings or binders for pharmaceutical presentations
06/23/1999CN1220270A Improved process for stabilizing proteins
06/23/1999CN1043732C Medicine membrane for curing stomatocace
06/22/1999US5914367 Polymer protein composites and methods for their preparation and use
06/22/1999US5914352 Methods for the use of stabilized fluorocarbon emulsions
06/22/1999US5914347 By adding to a hydroxyalkyl cellulose, evaporating the solution or dispersion to dryness under an inert atmosphere to prepare a powder; imparts oxidation resistance
06/22/1999US5914345 Treatment with stimulus to induce altered levels of stress response or hear shock proteins
06/22/1999US5914334 Stable gel formulation for topical treatment of skin conditions
06/22/1999US5914323 Treating hypercalcemia of malignancy, metastatic bone disease and/or metabolic bone disease by administering an isotonic aqueous alendronate solution with a buffer to maintain the ph in the range 4 to 8 to prevent precipitation
06/22/1999US5914322 Treatment of disease and conditions
06/22/1999US5914314 Hyaluronic acid and its nontoxic salts facilitate penetration of immunosuppressent through underperfused or pathological tissue, including scar tissue
06/22/1999US5914312 Pretargeting methods and compounds
06/22/1999US5914234 Methods of detecting growth differentiation factor-11
06/22/1999US5914231 Carrier of cationic, water soluble or water dispersable polymer; for gene therapy
06/22/1999US5914132 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
06/22/1999US5914122 Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams
06/22/1999US5914118 Multi-layered drug containing film preparation having powder adhesive thereon
06/22/1999US5914098 Aerosol composition for forming a hydrated membrane, and applications thereof
06/22/1999US5914095 Polychelants containg amide bonds
06/22/1999CA2255155A1 Non-transfering cosmetic composition comprising a non-filming polymer-particle dispersion in a partially non-volatile oil phase
06/22/1999CA1340603C Tri-aza macrocycles and metal complexes thereof
06/19/1999WO1999032139A1 Improved interferon polymer conjugates
06/17/1999WO1999029839A1 Grafted copolymers as gene carriers
06/17/1999WO1999029838A1 Fibrinogen-converting enzyme hybrids
06/17/1999WO1999029758A1 Positively-charged poly[alpha-(omega-aminoalkyl)glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake
06/17/1999WO1999029735A1 Non-aqueous, heterogeneous polymerization process and reaction product obtained thereby
06/17/1999WO1999029732A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/17/1999WO1999029723A1 Recombinant nodavirus compositions and methods
06/17/1999WO1999029712A1 Peptide-based gemini compounds
06/17/1999WO1999029349A1 Transfection particles
06/17/1999WO1999029348A1 Pharmaceutical hydrogel formulations, drug delivery devices and methods
06/17/1999WO1999029338A1 Fibrinolytic inhibitor for sealant
06/17/1999WO1999029337A1 Stabilized teriparatide solutions
06/17/1999WO1999029336A1 Glp-1 formulations
06/17/1999WO1999029331A1 The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents
06/17/1999WO1999029328A1 Modified polysaccharides exhibiting altered biological recognition
06/17/1999WO1999029326A1 Creams containing vitamin d3 derivatives
06/17/1999WO1999029325A1 Lotions containing vitamin d3 derivatives
06/17/1999WO1999029322A1 Magnesium quinolone antibiotics
06/17/1999WO1999029320A1 Novel administration form comprising an acid-labile active compound
06/17/1999WO1999029305A1 Sustained release formulation containing three different types of polymers and tablet formed therefrom
06/17/1999WO1999029304A1 Method for high supercoiled dna content microspheres
06/17/1999WO1999029303A1 Biodegradable mixed polymeric micelles for gene delivery
06/17/1999WO1999029302A1 Drug delivery system with two-step targeting
06/17/1999WO1999029301A2 Lipid compositions and their use
06/17/1999WO1999029299A1 Novel suppository form comprising an acid-labile active compound
06/17/1999WO1999029296A1 Pharmaceutical aerosol compositions
06/17/1999WO1999029280A2 Anti-picornaviral ligands via a combinatorial computational and synthetic approach
06/17/1999WO1999024396A8 Ion binding compounds, radionuclide complexes, methods of making radionuclide complexes, methods of extracting radionucleides, and methods of delivering radionuclides to target locations
06/17/1999WO1999017742A3 Taste masked formulations
06/17/1999WO1999016420A9 Stabilized preparations for use in nebulizers
06/17/1999WO1999015210A3 Bioadhesive compositions and methods for topical administration of active agents
06/17/1999DE19756454C1 Surface-active compositions, especially cosmetics, containing glycerol carbonate as emulsifier
06/17/1999CA2693296A1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/17/1999CA2313405A1 Fibrinolytic inhibitor for sealant
06/17/1999CA2312941A1 Peptide-based gemini compounds
06/17/1999CA2312890A1 Transfection particles
06/17/1999CA2312731A1 Creams containing vitamin d3 derivatives
06/17/1999CA2312476A1 Fibrinogen-converting enzyme hybrids
06/17/1999CA2312190A1 Glp-1 formulations
06/17/1999CA2312060A1 Lotions containing vitamin d3 derivatives
06/16/1999EP0922464A1 Quickly disintegrable compression-molded materials and process for producing the same
06/16/1999EP0922463A2 Process for preparation of solid dosage forms
06/16/1999EP0922462A2 Process for preparation of solid dosage forms
06/16/1999EP0922457A1 Skin protection composition
06/16/1999EP0922449A2 Use of an enzymatically converted starch derivative as an encapsulating agent
06/16/1999EP0922446A1 Solution-phase site-specific preparation of GRF-PEG conjugates
06/16/1999EP0922071A1 Polycarboxylic based cross-linked copolymers
06/16/1999EP0921817A1 Pegylation process
06/16/1999EP0921812A1 INSULIN PREPARATIONS CONTAINING NaCl
06/16/1999EP0921811A2 Administration of histamine for therapeutic purposes
06/16/1999EP0921808A1 Non-aqueous polar aprotic peptide formulations
06/16/1999EP0921806A1 Mannose-6-phosphate composition and its use in treating fibrotic disorders
06/16/1999EP0921796A1 Tetrahydrolipstatin containing compositions
06/16/1999EP0921793A1 Solid, non-deliquescent formulations of sodium valproate
06/16/1999EP0921791A1 Composition comprising mupirocin and chlorhexidine
06/16/1999EP0921789A1 Taste masked liquid suspensions
06/16/1999EP0921756A1 Novel radiopharmaceutical compositions and matrices and uses thereof
06/16/1999EP0873127A4 Anthelmintic macrocyclic lactone compositions
06/16/1999EP0757690A4 Electron-deficient porphyrins and processes and intermediates for preparing same
06/16/1999EP0689415B1 Low-viscosity cosmetic and pharmaceutical emulsions
06/16/1999EP0581842B1 An organ specific emulsion
06/16/1999CN1219938A Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP)
06/16/1999CN1219919A Dissolvable oxides for biological applications
06/16/1999CN1219880A Acne treatment
06/16/1999CN1219879A Pharmaceutical compositions
06/16/1999CN1219874A Preparation for percutaneous administration
1 ... 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 ... 1712